These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6146068)
41. Lipomas as a potential cause for uptake of In-111 MAb72.3 (Oncoscint CR). Sakow NK; Japanwalla M; Tuckson WB; Shields RE Clin Nucl Med; 1996 Apr; 21(4):332-3. PubMed ID: 8925626 [No Abstract] [Full Text] [Related]
42. Indium-111-diethylenetriaminepentaacetic acid-octreotide is delivered in vivo to pancreatic, tumor cell, renal, and hepatocyte lysosomes. Duncan JR; Stephenson MT; Wu HP; Anderson CJ Cancer Res; 1997 Feb; 57(4):659-71. PubMed ID: 9044843 [TBL] [Abstract][Full Text] [Related]
43. Dual isotope study of iodine-125 and indium-111-labeled antibody in athymic mice. Carney PL; Rogers PE; Johnson DK J Nucl Med; 1989 Mar; 30(3):374-84. PubMed ID: 2738666 [TBL] [Abstract][Full Text] [Related]
44. Immunopharmacokinetics of 111In-CYT-103 in ovarian cancer patients. Jusko WJ; Kung LP; Schmelter RF Targeted Diagn Ther; 1992; 6():177-90. PubMed ID: 1576345 [No Abstract] [Full Text] [Related]
45. A tentative biological model for the localization of radiolabelled antibody in tumor: the importance of immunoreactivity. Larson SM Int J Rad Appl Instrum B; 1986; 13(4):393-9. PubMed ID: 3793493 [No Abstract] [Full Text] [Related]
46. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen. Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605 [TBL] [Abstract][Full Text] [Related]
47. [The behavior of 111In-DTPA in the cerebrospinal fluid--its relation to "spinal arachnoid villi"]. Kobayashi T; Kubo A Nihon Igaku Hoshasen Gakkai Zasshi; 1976 Dec; 36(12):1090-106. PubMed ID: 1071175 [No Abstract] [Full Text] [Related]
48. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody. Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032 [TBL] [Abstract][Full Text] [Related]
49. Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer. Yokoyama K; Carrasquillo JA; Chang AE; Colcher D; Roselli M; Sugarbaker P; Sindelar W; Reynolds JC; Perentesis P; Gansow OA J Nucl Med; 1989 Mar; 30(3):320-7. PubMed ID: 2738661 [TBL] [Abstract][Full Text] [Related]
50. [Cisternographic finding in spinocerebellar degeneration with 111 In-DTPA (author's transl)]. Fujita M; Miyazaki M; Kanao K; Honda M; Ishihara S Kaku Igaku; 1977 Aug; 14(4):451-60. PubMed ID: 926443 [No Abstract] [Full Text] [Related]
51. Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system. Hawkins GA; McCabe RP; Kim CH; Subramanian R; Bredehorst R; McCullers GA; Vogel CW; Hanna MG; Pomato N Cancer Res; 1993 May; 53(10 Suppl):2368-73. PubMed ID: 8485723 [TBL] [Abstract][Full Text] [Related]